ATXI AVENUE THERAPTC

-

AVENUE THERAPTC Reported Earnings

Friday, November 6, 2026 · 12:00 AM ET

AVENUE THERAPTC (ATXI) reported a loss of $0.20 per share on revenue of $0.00 million for the . .

Avenue Therapeutics, Inc. is a specialty pharmaceutical company. It acquires, licenses, develops and commercializes products principally for use in the acute/intensive care hospital setting. Avenue Therapeutics, Inc. is based in New York, United States.

Earnings Whisper Grade —
Power Rating—
Reported Earnings
($0.20)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth4.8 %
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—